Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Mylan receives FDA approval for generic verapamil

Oct. 9, 1997

Octreotide assessed in treatment of restenosis in VERAS study

Oct. 9, 1997

GenVec/Parke-Davis collaboration focusing on angiogenic products

Oct. 8, 1997

New antiarrhythmics from American Cyanamid

Oct. 8, 1997

Key cardiovascular gene therapy patent awarded to CardioGene Therapeutics

Oct. 8, 1997

Hoechst describes Na+/H+-exchange inhibitors for ischemic disorders

Oct. 8, 1997

New discovery enhances feasibility of cardiovascular gene therapy

Oct. 8, 1997

FDA approves irbesartan for marketing

Oct. 8, 1997

Millennium and Lilly extend cardiovascular research collaboration

Oct. 7, 1997

HMR and Andrx agree to stipulation in Cardizem CD patent lawsuit

Oct. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...